Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/22354
Title: Dose-dense sequential chemotherapy with epirubicin and paclitaxel versus the combination, as first-line chemotherapy, in advanced breast cancer: a randomized study conducted by the Hellenic Cooperative Oncology Group
Institution and School/Department of submitter: Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής
Keywords: Adult,Aged,Antineoplastic Combined Chemotherapy Protocols/*therapeutic use,Breast Neoplasms/*drug therapy/pathology,Disease Progression,Dose-Response Relationship, Drug,Drug Administration Schedule,Epirubicin/administration & dosage,Female,Granulocyte Colony-Stimulating Factor/administration & dosage,Humans,Male,Middle Aged,Neutropenia/chemically induced,Paclitaxel/administration & dosage,Survival Analysis,Treatment Outcome
URI: https://olympias.lib.uoi.gr/jspui/handle/123456789/22354
ISSN: 0732-183X
Link: http://www.ncbi.nlm.nih.gov/pubmed/11304776
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ

Files in This Item:
File Description SizeFormat 
Pavlidis-2001-dose dense sequential.pdf85.7 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons